Advertisement
European Society for Vascular Surgery
Advanced searchSave search
Abstract| Volume 65, ISSUE 1, e12, January 2023

Direct oral anticoagulant agents might be safe for patients undergoing endovenous radiofrequency and laser ablation

Presented at the Superficial Venous Disease and Imaging Scientific Session of the Thirty-fourth American Venous Forum Annual Meeting, Orlando, FL, February 23-26, 2022.
DOI:https://doi.org/10.1016/j.ejvs.2022.12.019
Direct oral anticoagulant agents might be safe for patients undergoing endovenous radiofrequency and laser ablation
Previous ArticleOutcomes of a bypass-first strategy in chronic limb-threatening ischemia based on the Global Vascular Guidelines
Next ArticleIncidence of venous thromboembolism in patients with peripheral arterial disease after endovascular intervention
      Objective: Studies assessing the effect of the use of anticoagulant agents on endovenous thermal ablation (ETA) have been limited to patients taking warfarin. Thus, the aim of the present study was to assess the efficacy and safety of ETA for patients taking direct oral anticoagulants (DOACs). We hypothesized that the outcome of ETA for patients taking DOACs would not be superior to the outcomes for patients taking DOACs.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to European Journal of Vascular and Endovascular Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      Article info

      Publication history

      From the American Venous Forum

      Identification

      DOI: https://doi.org/10.1016/j.ejvs.2022.12.019

      Copyright

      © 2022 Published by Elsevier Inc.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX